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ABSTRACT Coupling atomic force microscopy (AFM) with high-resolution ﬂuorescence microscopy is an attractive means of
identifying membrane domains by both physical topography and ﬂuorescence. We have used this approach to study the ability
of a suite of ﬂuorescent molecules to probe domain structures in supported planar bilayers. These included BODIPY-labeled
ganglioside, sphingomyelin, and three new cholesterol derivatives, as well as NBD-labeled phosphatidylcholine, sphingomyelin,
and cholesterol. Interestingly, many ﬂuorescent lipid probes, including derivatives of known raft-associated lipids, preferentially
partitioned into topographical features consistent with nonraft domains. This suggests that the covalent attachment of a small
ﬂuorophore to a lipid molecule can abolish its ability to associate with rafts. In addition, the localization of one of the BODIPY-
cholesterol derivatives was dependent on the lipid composition of the bilayer. These data suggest that conclusions about the
identiﬁcation of membrane domains in supported planar bilayers on the basis of ﬂuorescent lipid probes alone must be inter-
preted with caution. The combination of AFM with ﬂuorescence microscopy represents a more rigorous means of identifying
lipid domains in supported bilayers.
INTRODUCTION
Lipid microdomains, or rafts, formed as a result of speciﬁc
lipid-lipid or lipid-protein interactions in the cell membrane,
are thought to play an important role in regulating signal
transduction, cellular transport, and lipid sorting (1–8). Ap-
plying ﬂuorescence microscopy or spectroscopy to study
these structures and their dynamics in vivo is a challenge be-
cause of the lack of adequate imaging techniques with
sufﬁcient spatial and/or temporal resolution (9) as well as the
limited number of speciﬁc lipid antibodies or lipid-binding
protein domains that are available to serve as probes (10,11).
Incorporating an artiﬁcial chromophore such as NBD,
BODIPY, anthracene, pyrene, diphenylhexatriene, or a poly-
ene chain into one of the fatty acid side chains is a common
strategy to create ﬂuorescent lipids to study metabolism,
cellular transport, and distribution of lipids (12). The ma-
jority of these probes were introduced before the importance
of lipid phase separation was recognized. Recently it has
been demonstrated, using ﬂuorescence quenching assays
with model membranes (12–15), that chemical modiﬁcation
of a raft-associated lipid with a ﬂuorophore can alter its abi-
lity to remain associated with (or associate to) these domains
(15–17). In addition, correlated atomic force-ﬂuorescence
microscopic methods have recently shown promise in visu-
alizing microdomains and ﬂuorescence probe distribution
simultaneously (18–21), including the effect of extrinsic
markers on the morphology of lipid monolayers (22). This
study was motivated by the realization that atomic force
microscopy (AFM) can detect membrane microdomains
using the differences in height between lipids existing in
different phase regimes (20,23–26), including rafts or liquid-
ordered (lo) phases reported to be ;0.5–1 nm above the
surrounding liquid-disordered (ld) phase in model mem-
branes composed of DOPC/sphingomyelin (SM)/cholesterol
(Chl) (27–31). Herein we describe the use of simultaneous
coupled AFM-confocal imaging to investigate the ability of
the various lipids such as ganglioside GM1, phosphatidyl-
choline, SM, and Chl labeled with NBD or BODIPY, to
partition into the lo or ld domains of phase-segregated planar
lipid bilayers. Our ﬁndings demonstrate that correlated AFM/
ﬂuorescence microscopy is a simple approach for identifying
the preferential localization of ﬂuorescent lipid probes. The
attachment of a ﬂuorophore such as NBD or BODIPY on the
acyl chain of a saturated lipid or of Chl generally decreases
the afﬁnity of the lipid or sterol for the more ordered domains.
MATERIALS AND METHODS
Materials
N-stearoyl-D-erythro-sphingosylphosphorylcholine (synSM, 18:0), 1,2-
dioleoyl-sn-glycerol-3-phosphocholine (DOPC, 18:1), brain bovine GM1
ammonium salt (brain GM1), 1-palmitoyl-2-(6-[(7-nitro-2-1,3-benzoxadiazol-
4-yl)amino]hexanoyl)-sn-glycero-3-phosphocholine (NBD-PC) (Fig. 1 A),
25-(N-[(7-nitro-2-1,3-benzoxadiazol-4-yl)methyl] amino]-27-norcholesterol
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(NBD-Cholesterol) (Fig. 1 B), and N-(12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino)dodecanoyl]sphingosine-1-phosphocholine (NBD-SM) (Fig. 1 C)
were purchased from Avanti Polar Lipids (Alabaster, AL). Chl was
purchased from Sigma-Aldrich Canada (Oakville, ON, Canada). BODIPY
FL C5-ganglioside GM1 (BODIPY-GM1) (Fig. 1 D) and Alexa Fluor 555
cholera toxin subunit B (Alexa555-CTX-B) were purchased from Invitrogen
Canada (Burlington, ON, Canada). BODIPY-Chl analogs (1, 2, and 3) (Fig.
1, E1, E2, and F) were synthesized as described (Z. Li, E. Mintzer, and
R. Bittman, unpublished). BODIPY-SM (Fig. 1 G) was synthesized by
N-acylation of sphingosylphosphorylcholine with a p-nitrophenyl ester of a
BODIPY-fatty acid conjugate.
Liposome preparation
The liposomes were prepared by dissolving the required amounts of the
various lipids in chloroform or chloroform/methanol (2:1), removing the
FIGURE 1 Chemical structures of (A) NBD-PC, (B) NBD-Chl, (C) NBD-SM, (D) BODIPY-GM1, (E1 and E2) BODIPY-Chl 1 and 2, (F) BODIPY-Chl 3,
and (G) BODIPY-SM.
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solvent by rotary evaporation and keeping the ﬁlms under vacuum for 3–4 h
to remove occluded solvent. The lipid ﬁlms were hydrated with 10 mM
HEPES buffer containing 150 mM NaCl at pH 7.4 to a ﬁnal lipid
concentration of;1 mM. Unilamellar vesicles were formed by sonication in
a heated ultrasonic cleaner (;60C) until the suspension became clear or
only slightly hazy.
Supported planar bilayer preparation
Supported planar bilayers (SPBs) were formed by in situ fusion of 100 ml of
1 mM liposome suspension containing the desired lipid composition and 400
ml of 10 mMHEPES buffer, pH 7.4, containing 4 mM CaCl2, 150 mMNaCl,
onto a freshly cleaved mica disc (;25 mm in diameter and ;0.17 mm in
thickness) held in a custom-made open ﬂuid cell. The liposomes were ﬁrst
allowed to fuse at ambient temperature for 3 min, heated in place to 70C for 3
min, and then allowed to cool to room temperature. This heating-cooling step
facilitated the nucleation and growth of micron-size gel-phase domains, as has
been reported by others (32). This preparation step was performed in place on
the AFM-confocal-total internal reﬂection ﬂuorescence (TIRF) instrument, as
described in the following section.
Coaxial confocal-AFM imaging
All imaging was performed using an integrated AFM-confocal-TIRF imag-
ing system. In this system, a confocal microscope (FluoView 500, Olympus,
Melville, NY) was combined into a single imaging platform with an atomic
force microscope (Nanoscope IIIa Bioscope, Digital Instruments/Veeco,
Santa Barbara, CA) through an Olympus IX70 inverted microscope base. All
confocal images were acquired using an Olympus 603 TIRF objective (NA
; 1.45). SPBs were formed in situ as described earlier. The ﬂuid cell was
washed sequentially with pH 7.4 buffers containing 10 mM HEPES, 4 mM
CaCl2, 150 mM NaCl, followed by 10 mM HEPES, 4 mM EDTA, 150 mM
NaCl, and ﬁnally 10 mM HEPES, 150 mM NaCl to remove excess solution
liposomes before confocal-AFM imaging. All procedures were performed in
the dark to avoid photobleaching of the ﬂuorophores. Once the formation of
the SPB was conﬁrmed by AFM and confocal imaging, for some
experiments a small volume of concentrated Alexa555 CTX-B stock
solution (;1 mg/ml) was injected into the custom-designed open ﬂuid cell,
allowing it to distribute evenly by diffusion. From the total quantity of the
toxin injected and the total cell volume immediately after injection, the ﬁnal
concentration of CTX-B was estimated to be ;1 mg/ml. All BODIPY- and
FIGURE 2 Simultaneous AFM-confocal imag-
ing of reconstituted rafts in model SPBs composed
of 34 mol % DOPC/34 mol % synSM (C18)/30
mol % Chl/2 mol % brain GM1 with (A) 0.2%
NBD-SM or (B) 0.2 mol % BODIPY-SM.
Alexa555-CTX-B was added to locate the gan-
glioside receptor GM1, a raft-associated lipid.
(Inset) Corresponding section analysis along
A-A9 and B-B9.
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NBD-containing compounds were excited by an Ar-ion 488 nm laser, and
the emission was collected using a photomultiplier tube (PMT) ﬁtted with a
510–525 nm band-pass ﬁlter. A 543 nm HeNe laser was used to excite the
Alexa555 ﬂuorophores, and the Alexa555 ﬂuorescence was captured using
another PMT equipped with a 560-nm high-pass ﬁlter. Confocal pinholes for
both PMTs were set at 800 mm to maximize ﬂuorescence counts emitted by
the ﬂuorophores. The BODIPY/NBD and Alexa555 ﬂuorophores were
sequentially excited to minimize possible cross talk between the BODIPY/
NBD and Alexa555 PMT channels.
Although the ﬂuorescence and AFM images are collected simulta-
neously, there are differences in the timescale of imaging and the actual area
being imaged by the two techniques. The AFM data were collected as 5123
512 pixel 16-bit images at a typical line scan rate of 1.2 Hz, whereas the
1024 3 1024 pixel 12-bit confocal images were acquired at a line scan rate
of ;105 Hz. It is also important to note that the region imaged by the AFM
is a subset of the confocal microscope’s ﬁeld of view. This is a result of the
limited (;125 mm 3 ;125 mm) scan window afforded the AFM scanner
compared with the much larger ﬁeld of view provided by the 603 objective
used by the confocal microscope.
Image analysis
AFM image analysis was conducted using the Digital Instruments Nanoscope
software (version 4.42r9). Height images were ﬂattened and plane-ﬁt in the
x-scan direction. Quantitative height measurements were determined by sec-
tion analysis and shown as an average of 50 measurements. Contrast adjust-
ments for the ﬂuorescent images were made using ImagePro Plus (version 4.5,
Silver Spring, MD) or the public domain program ImageJ (developed at the
U.S. National Institutes of Health and available on the Internet at http://
rsb.info.nih.gov/ij). AFM-confocal image correlation was accomplished using
Adobe Photoshop or custom in-house developed Java software.
RESULTS AND DISCUSSION
Binding of cholera toxin to GM1
SimultaneousAFM-confocal imaging at ambient temperature
(;23C) revealed that SPBs containing 1:1 DOPC/SM/30
FIGURE 3 Simultaneous AFM-confocal im-
aging of reconstituted rafts in model SPBs
composed of 34 mol % DOPC/34 mol %
SynSM (C18)/30 mol % Chl/2 mol % brain
GM1 with (A) 0.2 mol % BODIPY-GM1 or (B)
0.2 mol % NBD-PC. Alexa555-CTX-B was
added to locate the ganglioside receptor GM1, a
raft-associated lipid. (Inset) Corresponding
section analysis along A-A9 and B-B9.
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mol % Chl/2 mol % brain GM1 formed phase-segregated high
(lo) and low (ld) domains with an average height difference of
;1 nm, regardless of the type of exogenous SM (synSM, 18:0
or 16:0, or brain SM) or ﬂuorescently labeled component. Not
unexpectedly, we were unable to resolve the individual GM1
molecules by AFM. This is likely a consequence of the
ﬂexibility of the GM1 headgroup. Accordingly, to visualize
the GM1-containing domains, the B-subunit of CTX-B, labeled
with Alexa555, was introduced into the AFM ﬂuid cell.
It is well known that CTX-B binds to the GM1 headgroup
to form, depending on the local GM1 concentration, well-
ordered two-dimensional crystalline arrays extending ;2.5
nm in height above GM1-containing domains (18,19,33).
Although our correlated AFM/confocal imaging conﬁrmed
that Alexa555-CTX-B was associated with the higher
domains, we were unable to resolve the individual CTX-B
molecules by topography imaging, nor was the expected
increase in height attributable to association of the labeled
CTX-B to the GM1 molecules in the lo domains detected.
This is likely a consequence of the low;2 mol % brain GM1
in the lo domains and incomplete coverage by CTX-B as a
densely packed two-dimensional monolayer. However, we
were able to resolve a direct spatial correspondence between
ﬂuorescence intensity and the lo domains, as identiﬁed by in
situ AFM (see yellow arrows in Fig. 2 A).
BODIPY-SM and NBD-SM preferentially partition
into the ld domains
A consequence of its long alkyl chains and corresponding
high melting temperatures, SM is expected to be colocalized
with the taller GM1-containing high domains, a model that
has been supported by x-ray diffraction studies (34). Sur-
prisingly, our correlated AFM/confocal imaging revealed
that BODIPY and NBD analogs of SM in fact preferentially
localize in the lower (ld) domains (Fig. 2). In the BODIPY
FIGURE 4 Simultaneous AFM-confocal imaging of re-
constituted rafts in model SPBs composed of 34 mol %
DOPC/34 mol % SynSM (C18)/28 mol % Chl/2 mol % brain
GM1 with (A) 2 mol % NBD-Chl, (B) 34 mol % DOPC/34
mol % SynSM (C18)/30 mol % Chl/2 mol % brain GM1
with 0.2 mol % BODIPY-Chl 1, or (C) 0.2 mol % BODIPY-
Chl 3. Alexa555-CTX-B was added to locate the gan-
glioside receptor GM1, a raft-associated lipid. (Inset)
Corresponding section analysis along A-A9, B-B9, and
C-C9 in the AFM topography images.
2174 Shaw et al.
Biophysical Journal 90(6) 2170–2178
and NBD-labeled lipids, one of the fatty acyl chains was
replaced with an NBD- or BODIPY-labeled acyl chain. A
recent study using a headgroup-labeled BODIPY-GM1
revealed that it failed to enter a more ordered gel domain,
whereas a headgroup labeled Alexa488-GM1 preferentially
partitioned into the gel domain (19). These data strongly
suggest that phase partitioning of ﬂuorophores between
domains is a complex phenomenon that depends not only on
the site of ﬂuorophore attachment but also on the physical
properties of the ﬂuorophore.
BODIPY-GM1 and NBD-PC preferentially partition
into the ld domains
Simultaneous AFM-confocal imaging at ambient tempera-
ture (;23C) revealed that SPBs containing 1:1 DOPC/
synSM, 18:0/30 mol % Chl/2 mol % brain GM1/0.2 mol %
BODIPY-GM1 and 0.2 mol % of NBD-PC, phase-segregated
into high (lo) and low (ld) domains with height difference
ranging from ;0.5 to 1.5 nm, in agreement with previous
AFM and x-ray diffraction studies (28–30,33). NBD-PC is
known to partition into ld phase (32,34–36), whereas CTX-B
is known to strongly associate with the ganglioside GM1 (34).
Close inspection revealed that the green ﬂuorescence arising
from the BODIPY and NBD labels was predominately lo-
calized to the low domains (ld), whereas the red ﬂuorescence
associated with Alexa555 labeled CTX-B remained mainly
associated with the tall (lo) domains (Fig. 3). Our data sug-
gest that brain GM1 preferentially segregates to the tall (lo)
domains, whereas BODIPY-GM1 localizes preferentially in
the nonraft domains. One would expect that there would be
some binding of CTX-B to the low domain because of the
FIGURE 5 Simultaneous AFM-confocal imaging of
reconstituted rafts in model SPBs composed of (A–B) 34
mol % SynSM (C18)/34 mol % DOPC/30 mol % Chl/2
mol % brain GM1 with 0.2 mol % BODIPY-Chl 2 or (C–D)
34 mol % SynSM (C16)/34 mol % DOPC/30 mol % Chl/2
mol % brain GM1 with 0.2 mol % BODIPY-Chl 2.
Alexa555-CTX-B was added to locate the ganglioside
receptor GM1, a raft-associated lipid. (Inset) Corresponding
section analysis along A-A9, B-B9, C-C9, and D-D9 in the
AFM topography images.
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presence of the BODIPY GM1; however, the relative ﬂuo-
rescence intensity of CTX-B would be much higher in the
high domain because of the 10-fold higher content of brain
GM1 (the molar ratio of brain GM1/BODIPY GM1 is 10:1, in
this case). Although CTX-B is known to induce clustering of
GM1 (37–39), it is not likely that the introduction of CTX-B
would result in the translocation of BODIPY-GM1 from the
low to high domains. Thus, this Alexa555-CTX-B labeling
experiment demonstrates that the unmodiﬁed GM1 sequesters
into the high domains as expected; however, it also clearly
reveals that BODIPY-GM1 unexpectedly associates with the
lower, nonraft, domains (Fig. 3).
Domain partitioning of ﬂuorescently
labeled cholesterol
A major constituent of eukaryotic membranes, Chl plays a
critical role in deﬁning membrane structure and function
(40), including regulating lipid trafﬁcking and sorting (41).
Our correlated AFM-ﬂuorescence data clearly reveal that
NBD-Chl and BODIPY-Chl 1 and 3 do not distribute pref-
erentially in the lo phase (Fig. 4), which is enriched in Chl
and sphingolipids (8). The side chain of Chl resides in the
bilayer interior (40,42); however, the NBD group, which is
generally considered to reside deep in the bilayer (43), was
reduced when a water-soluble reducing agent (dithionite)
was added to NBD-Chl-containing bilayers (44), indicating
that the NBD moiety at C25 of Chl can loop back toward the
lipid/water interface. Our study agrees with a recent ﬁnding
that NBD-Chl (45) does not mimic Chl (44,46).
BODIPY-Chl 3 is an analog of coprostanol. Although
structurally related to Chl, this analog was designed not to
mimic Chl, but to serve as a nonraft probe. Since the sterol
nucleus is not ﬂat in BODIPY-Chl 3, this compound would
differ from natural Chl with respect to lipid-lipid interac-
tions, consistent with the results from this study.
BODIPY-Chl 2 is a more faithful mimic of Chl since it
retains the planar conformation of the Chl ring system and
does not contain any polar atoms linking BODIPY to the
sterol ring. This is in agreement with our ﬁndings that
BODIPY-Chl 2 partitions into a Triton X-100 low density
insoluble fraction, whereas BODIPY-Chl 3 does not (47).
Nevertheless, the localization of BODIPY-Chl 2 within the
bilayer is dependent on the type of SM used to form the
SPBs. For instance, BODIPY-Chl 2 distributes uniformly
across the higher (lo) and the lower (ld) domains in bilayers
containing synSM 18:0. As shown in Fig. 5 A, binding of
Alexa555-CTX-B induced quenching of BODIPY ﬂuores-
cence at the higher (ld) domains. Sequestering of BODIPY
dyes or resonance energy transfer between BODIPY and
Alexa555 are possible mechanisms that can result in
localized quenching of BODIPY ﬂuorescence. The exact
mechanisms remain unclear. In contrast, BODIPY-Chl 2
preferentially partitioned into the lower domains in the
bilayers containing synSM 16:0 (Fig. 5 B) and preferentially
localized in the higher (lo) domains in bilayers containing
brain SM (Fig. 6).
The higher hydrophobicity of BODIPY relative to NBD
allows for better insertion into the bilayer (17,48). However,
this does not guarantee that a BODIPY-bearing lipid would
preferentially partition into the more ordered (lo) phase, as
shown by the behavior of BODIPY-GM1 and BODIPY-SM.
Different linkers that connect the BODIPY and the sterol
side chain result in differences among BODIPY-Chl analogs.
The linker coupling BODIPY to the sterol in BODIPY-Chl
1 contains an ester functionality, whereas in BODIPY-Chl 2
a short linker devoid of oxygen atoms was employed. Inter-
estingly, a relatively small change in structure from BODIPY-
Chl-1 to BODIPY-Chl-2 can change the location of the
sterol. The sensitivity of the domain partitioning of BODIPY-
Chl 2 to the nature of the surrounding lipid is illustrated by
the change caused by the nature of the SM (Figs. 5 and 6).
FIGURE 6 Simultaneous AFM-confocal imaging of
reconstituted rafts in model SPBs composed of 35 mol %
DOPC/35 mol % brain SM/28 mol % Chl/2 mol %
BODIPY-Chl 2. (Inset) Corresponding section analysis
along A-A9.
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IMPLICATIONS AND CONSIDERATIONS
Although our confocal images show signiﬁcant contrast as-
sociated with the segregation of the dyes into different spatial
domains, it should be noted that the ﬂuorescence intensity in
the two domains depends not only on the concentration of
the ﬂuorophore in that domain, but also on its quantum yield
in that particular domain. We have not quantitatively deter-
mined the partition coefﬁcient of the dyes examined in our
studies, but rather used the correlated AFM approach to as-
sign and assess the phases that the dyes are in favor of stain-
ing. Using planar supported lipid bilayers to study membrane
or protein-membrane dynamics and interactions allows us to
systematically vary lipid composition and to employ the cor-
related AFM-confocal approach with very little ambiguity in
the results. Planar supported lipid bilayers lack membrane
curvatures that are present in the spherical model membranes
such as giant unilamellar vesicles (GUVs) or cell membranes.
However, it has been demonstrated that GUVs partition into
liquid/liquid immiscible domains in the same way that planar
supported lipid bilayers do, and the lipids in both leaﬂets of
the supported bilayers are freely mobile (49).
CONCLUSIONS
Our studies have several important implications. Upon
conjugation with NBD or BODIPY, the lipids examined in
this study with the exception of BODIPY-Chl 2, and that had
been shown to associate with raft domains in the absence of
the ﬂuorophore no longer preferentially segregated to the
taller raft domains. This is consistent with previous reports
(12,15). Topographical AFM can provide details of the physi-
cal structure of the domains where the ﬂuorescent probes are
preferentially located. This correlated approach is an excel-
lent means of investigating the partitioning of ﬂuorescent
probes in a coexisting raft/nonraft system. In addition, this
study illustrates the possible adverse effects arising from the
use of NBD- and BODIPY-labels to identify raft domains.
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